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Diurnal patterns of circulating leptin concentrations are at-
tenuated after consumption of fructose-sweetened beverages
comparedwithglucose-sweetenedbeverages, likelya result of
limited postprandial glucose and insulin excursions after
fructose. Differences in postprandial exposure of adipose tis-
sue to peripheral circulating fructose and glucose or in adi-
pocyte metabolism of the two sugars may also be involved.
Thus, we compared plasma leptin concentrations after 6-h iv
infusions of saline, glucose, or fructose (15mg/kgmin) in over-
night-fasted adult rhesus monkeys (n  9). Despite increases
of plasma fructose from undetectable levels to about 2 mM
during fructose infusion, plasma leptin concentrations did
not increase, and the change of insulin was only about 10% of
that seen during glucose infusion. During glucose infusion,
plasma leptin was significantly increased above baseline con-
centrations by 240 min and increased steadily until the final
480-min time point (change in leptin  2.5  0.9 ng/ml, P <
0.001 vs. saline; percent change in leptin55 16%;P< 0.005
vs. saline). Substantial anaerobic metabolism of fructose was
suggested by a large increase of steady-state plasma lactate
(change in lactate  1.64  0.15 mM from baseline), which was
significantly greater than that during glucose (0.53  0.14
mM) or saline (0.51  0.14 mM) infusions (P < 0.001). There-
fore, increased adipose exposure to fructose and an active
whole-body anaerobic fructose metabolism are not sufficient
to increase circulating leptin levels in rhesus monkeys. Thus,
additional factors (i.e. limited post-fructose insulin excur-
sions and/or hexose-specific differences in adipocyte metab-
olism) are likely to underlie disparate effects of fructose and
glucose to increase circulating leptin concentrations. (Endo-
crinology 149: 3002–3008, 2008)
PATTERNS OF SUGAR consumption in the U.S. popu-lation have changedmarkedly in the last three decades,
with increasing calories derived from added sweeteners.
Based on U.S. national food disappearance data, yearly per
capita caloric sweetener consumption is estimated to have
risen 19% during the period 1970–2005 (U.S. Department of
Agriculture-Economic Research Service http://www.ers.
usda.gov/Data/FoodConsumption/FoodAvailQueriable.aspx).
It is estimated that sugar (glucose, fructose, and sucrose)
constitutes about 24% of daily energy intake in the adult U.S.
population (1), with calorically sweetened beverages ac-
counting formore than 10% of daily energy requirements (2).
Sweetened beverages have been implicated by some as a
factor contributing to the rising obesity prevalence in the
United States (3, 4). It has been proposed that it is the fructose
component of sucrose (50% fructose) and high-fructose corn
syrup (HFCS, 42–55% fructose) that contributes to the effects
of overconsumption of sweetened beverages to promote
weight gain, dysregulation of lipid metabolism, and insulin
resistance/glucose intolerance (1, 4, 5). Nevertheless, whether
increased intake of fructose from sucrose and HFCS is a major
contributing factor to the recent obesity epidemic remains open
to debate (6), and other trends such as total caloric intake (in-
creased 20% over the last three decades) and relatively low
physical activity levels are alsohighly likely tohave contributed
to the increased prevalence of obesity and its associated met-
abolic disorders.
Assessment of the health impacts of consuming fructose
and other dietary sugars will benefit from a greater under-
standing of the physiological changes accompanying their
metabolism. In particular, studies are warranted that help
clarify the mechanisms by which fructose influences metab-
olism and endocrine systems regulating energy homeostasis.
In the context of a meal, fructose ingestion, whether by itself
of as part of sucrose or HFCS, can result in sustained ele-
vations of postprandial triglyceride levels in humans (7–10).
This is likely explained by substantial hepatic flux of dietary
fructose through fructokinase to triose phosphates, thus by-
passing regulation at phosphofructokinase to provide lipo-
genic substrate in the postprandial state. With respect to
hormonal profiles, compared with subjects consuming glu-
cose-sweetened beverages with meals, consuming fructose
beverages with each meal over the course of a day resulted
in attenuated postprandial blood insulin and glucose-depen-
dent insulinotropic polypeptide (GIP) levels, reduced post-
prandial and diurnal circulating leptin concentration, and
blunted postmeal suppression of plasma ghrelin concentra-
tions (9). The insulin and GIP results in this study were
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Abbreviations: GIP, Glucose-dependent insulinotropic polypeptide;
G6PDH, glucose-6-phosphate dehydrogenase; PGI, phosphoglucose
isomerase; HFCS, high-fructose corn syrup; -NADP, -nicotinamide
adenine dinucleotide phosphate; NADPH, reduced NADP.
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consistent with other human studies in which postprandial
insulin and GIP responses were not evident after intraduo-
denal infusion or oral administration of fructose, unlike glu-
cose infusion that produced large increases in these hor-
mones (11, 12). Therefore, existing data indicate that high
intakes of dietary fructose have the potential to promote
undesirable effects on lipids and can produce an endocrine
profile associated with body weight gain.
The mechanisms that underlie reduced postprandial and
diurnal leptin responses after consumption of fructose re-
main to be fully explained.However, at least twopossibilities
exist. First, it is known that insulin stimulates leptin expres-
sion and secretion from adipocytes (13–16). Increased oxi-
dative glucosemetabolism is a key contributor to this process
(17–19), which appears to involve the glucose- and insulin-
regulated transcription factor Sp1 (20). It is possible that
adipocyte uptake and metabolism of fructose differs from
glucose and hence does not trigger leptin production to an
equivalent degree. Second, the reduced leptin excursions
after fructose consumption might be explained by relatively
limited adipose tissue exposure to fructose because, as re-
viewed by Gaby (21), peak plasma concentrations of periph-
eral fructose after oral fructose challenges in humans are
quite low (to0.3–0.5 mm). We have observed similarly low
fructose excursions in individuals consuming a beverage
sweetened with 45 g fructose with mixed meals (Teff, K. L.,
S. H. Adams, and P. J. Havel, unpublished). This contrasts
with circulating glucose concentrations, which peaked at
about 2–5 mm above baseline fasting glucose concentrations
when 45 g glucose was ingested with meals in the same
subjects (9). Peripheral blood fructose levels after fructose
consumption are attenuated by several factors: 1) when ad-
ministered independently as single sugars, the rate of small
intestinal uptake of fructose is significantly reduced com-
pared with glucose (22–25); 2) relatively high metabolism of
fructose to lactate occurs after fructose administration (9,
26–31); and 3) the liver extracts a large fraction of fructose
arriving via the portal circulation, estimated from portal-
arterial concentration differences to be about 50–80% in rats
(27, 32–34), about 65–80% in baboons (35), and about 70–80%
in humans (36, 37).
Considering the uncertainties concerning the relative roles
of postprandial circulating fructose levels or adipocyte fruc-
tosemetabolism in the regulation of leptin production in vivo,
in the present study, we measured plasma leptin responses
to iv saline, fructose, or glucose administration in adult male
rhesus monkeys. We hypothesized that fructose, unlike glu-
cose, is a poor stimulus for leptin production even when its
systemic availability is increased through iv infusion of the
sugar.
Materials and Methods
Animals
The studies were conducted at the California National Primate Re-
search Center (CNPRC) on the University of California, Davis, campus.
The experimental protocol was performed in accordancewith the guide-
lines of the U.S. Animal Welfare Act and after approval by the CNPRC
Research Advisory Committee and the University of California, Davis,
Institutional Animal Use and Care Committee. The CNPRC is an As-
sociation for Assessment and Accreditation of Laboratory Animal Care
accredited facility. Nine adult (age 11–14 yr) male rhesus monkeys
(Macaca mulatta) weighing 8.6–15.9 kg (mean  sem  11.7  0.8 kg)
were used for these studies. Before selection for the study, a physical
examination, complete blood count, and serum biochemistry panel was
performed on each animal to exclude animals with signs of disease. The
animals had previously been acclimated to several hours of chair re-
straint with a minimum of 10 training sessions (38), allowing for the
studies to be conducted in conscious, unstressed animals.
Infusion protocol
Each animalwas studied three times in a randomized order: 1) during
saline infusion, 2) during glucose infusion, and 3) during fructose in-
fusion. The studies were performed at least 7 d apart. The animals were
fasted overnight and placed in restraint chairs at least 1 h before each
experiment. Both right and left arm veins were catheterized, one for the
infusion of sterile saline, glucose (sterile 50% dextrose solution in deion-
izedwater), or fructose (sterile 50% fructose solution in deionizedwater)
and the other for blood sampling. Two baseline blood samples (3 ml
each) were drawn from one catheter at 10 and 0 min and placed into
tubes containing EDTA. Saline or glucose and fructose were infused into
the contralateral catheter at a rate of 15 mg/kgmin. Blood samples were
collected at 5, 15, 30, 60, 90, 120, 180, 240, 300, and 360 min during the
infusions. At this time, the infusions were discontinued, the catheters
were removed, and the animals were returned to their home cages. A
final blood sample was taken 2 h later (at t 480 min) from an arm vein
while the animals remained in their cages. Samples were placed on ice
until centrifuged to obtain plasma, which was frozen at 80 C until
analyses for metabolites and hormones as described below.
Hormone and metabolite assays
Glucose and lactate were determined using a YSI Model 2300 Glu-
cose-Lactate Analyzer (Yellow Springs, OH). Plasma triglycerides were
assayed using a glycerol-3-phosphate-oxidase-based colorimetric kit per
manufacturer’s instructions (Infinity triglycerides kit TR22421; Thermo,
Waltham, MA) and using a Wallac Victor 2 plate reader (PerkinElmer,
Waltham, MA). Plasma insulin concentrations were measured with a
human insulin RIA kit (HI-14K; Linco Research, St. Louis, MO), and
leptin concentrations were assayed using a primate leptin RIA kit (PL-
84K; Linco).
Plasma fructose assay
Plasma fructose concentrations were determined using a modifica-
tion of a commercial glucose/fructose analytical kit (Megazyme, catalog
item K-FRUGL; Xygen Diagnostics Inc., Burgessville, Ontario, Canada)
that contains the following: bottle 1 (2 m imidazole buffer plus magne-
sium chloride and sodium azide, pH 7.6), bottle 2 [-nicotinamide ad-
enine dinucleotide phosphate (-NADP) and ATP], bottle 3 [425 U/ml
hexokinase and 212 U/ml glucose-6-phosphate dehydrogenase
(G6PDH)], and bottle 4 [1000 U/ml phosphoglucose isomerase (PGI)].
For each analysis, fresh assay buffer was made by mixing dionized
water, bottle 1 contents, and bottle 2 contents (20:1:1). In each sample
well of a 96-well plate (BD Falcon UV-Transparent Microplate, item
353261), 220 l assay buffer and 10 l sample were added and mixed
using the plate shaker feature of a SpectraMax 340 PCMicroplate Reader
(Molecular Devices, Sunnyvale, CA) before adding 2 l bottle 3 contents
per well after which plates were mixed again. Incubations were con-
ducted at 30 C for 50 min in the warmed chamber of the plate reader,
and reduced NADP (NADPH) absorbance was measured at 340 nm as
a measure of sample glucose concentration (NADPH generation from
glucose-6-phosphate reaction with G6PDH). After this reading, 2 l PGI
per well was added and plates mixed and returned to 30 C. At 30 min,
NADPH absorbance was measured (PGI converts fructose-6-phosphate
to glucose-6-phosphate, with NADPH generation via G6PDH). The
change in absorbance from the previous reading was used to determine
fructose concentration from a standard curve. To account for matrix
effects, fructose standards were diluted in an EDTA-plasma matrix
(plasma from overnight-fasted human subjects containing no detectable
fructose).
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Statistics
A repeated-measures ANOVA was used to test for significant dif-
ferences in outcome variables when comparing saline, glucose, and
fructose treatments. Post hoc Bonferroni tests were performed when
significant treatment or time  treatment interactions were observed
(P  0.05), comparing parameters during glucose or fructose infusion
with saline controls and with one another.
Results
Plasma sugar and metabolite concentrations
Fructose was not detectable in plasma samples frommon-
keys in the fasted state (Fig. 1) or in a subset of the samples
collected from monkeys during glucose infusion (data not
shown). Fructose concentrations plateaued between 30 and
60 min during iv fructose infusion, whereas during glucose
infusion, plasma glucose peaked during this period and pla-
teaued somewhat later. Consistent with observations after
enteral or iv fructose administration in human subjects (9, 26,
28, 29, 31, 36, 37, 39–42), there was a small but significant
increase of plasma glucose concentrations during fructose
infusion in monkeys (Fig. 1). The magnitude of increase of
glucose concentrations during glucose infusion was mark-
edly (5-fold) larger compared with the increase of fructose
concentrations during fructose infusion (11 mm and 2
mm at plateau, respectively) (P  0.001).
Compared with glucose, enteral or iv fructose has been
reported to substantially increase circulating lactate concen-
trations in humans (9, 26, 28–31, 39–41, 43). In monkeys,
there was a significant effect of time (P  0.0001), treatment
(P  0.001), and a time  treatment interaction (P  0.0001)
for the change of plasma lactate concentrations after infusion,
with fructose infusion resulting in a large and sustained
increase relative to saline infusion and greater than that
observed during glucose infusion (Fig. 2A). Plasma levels of
lactate in fructose-infused monkeys plateaued by 60 min.
Plasma lactate concentrations were also significantly in-
creased during the infusion of glucose compared with saline
infusion (Fig. 2A).
After fructose-containing meals, increased plasma triglycer-
ide concentrations are typically observed in human subjects
(7–9). In the current studies inmonkeys, there was a significant
effect of time (P 0.0001), treatment (P 0.001), and a time
treatment interaction (P  0.0001) for the changes of plasma
triglycerides. Interestingly, we did not detect a significant in-
crease of plasma triglyceride concentrations during fructose
compared with saline infusion; however, during glucose infu-
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FIG. 1. Plasma concentrations of fructose and glucose in conscious
adult male rhesus monkeys receiving iv infusions of saline, glucose,
or fructose solutions over 360 min. All animals (n 9) underwent the
three treatments on different days in randomized order after a wash-
out period between treatments (see Materials and Methods). Com-
paredwith saline treatment, fructose (15mg/kgmin) elicited amodest
increase in glucose levels (90, 240, and 300 min, P  0.05; 360 min,
P  0.0001), whereas, as expected, during glucose infusion (15 mg/
kgmin), there was marked increase of plasma glucose. Fructose was
not detectable in plasma from fasted monkeys or during saline or
glucose infusion.
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FIG. 2. Changes of plasma lactate and plasma triglyceride concentra-
tions during 360-min iv infusions of saline, glucose, or fructose in adult
male rhesus monkeys. A, Plasma lactate concentrations were signifi-
cantly increased after glucose and fructose infusions compared with
saline infusion (*,P 0.05; ***,P 0.001) andwere consistently higher
after fructose compared with glucose (180 and 300 min, P  0.05; 360
min, P  0.01). Baseline lactate concentrations (calculated as the aver-
age of values from10 and 0min) were 1.98 0.50mM, 1.48 0.19mM
(glucose), and 1.89 0.33 mM (fructose). B, Plasma triglyceride concen-
trations decreased significantly during glucose infusion to levels below
those observed with saline (*, P  0.05; **, P  0.01; ***, P  0.001).
Differences in triglyceride levels comparing fructose to saline were not
statistically significant; however, levels during fructose infusion re-
mained significantly higher comparedwithduring glucose infusion at 90
min and beyond (90 and 360 min, P  0.01; 120–300 min, P  0.001).
Baseline fasting triglyceride concentrations were 54 3 mg/dl (saline),
53  3 mg/dl (glucose), and 50  3 mg/dl (fructose).
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sion, plasma triglycerides were significantly decreased com-
pared with saline or fructose infusion (Fig. 2B).
Plasma insulin and leptin concentrations
Insulin is an important stimulator of leptin production and
secretion, in large part due to its ability to increase glucose
uptake and metabolism in adipocytes (17–19) and through
Sp1-mediated transcription of the leptin gene (20). As ex-
pected, during glucose infusion, there was a marked and
sustained increase of plasma insulin concentrations com-
pared with that observed during saline infusion, whereas
during fructose infusion, there was a much smaller change
of plasma insulin than during glucose infusion (Fig. 3A).
There were significant effects of time (P 0.0001), treatment
(P  0.02), and a time  treatment interaction (P  0.0001)
for changes of plasma insulin during the infusions.
The attenuation of postprandial and diurnal circulating
leptin patterns after fructose consumption in humans (9)
could be a result of limited access of fructose to adipose
tissue, due to active hepatic uptake from the portal circula-
tion and/or rapid conversion of the sugar to other metabo-
lites such as lactate, which would result in substantially
diminished peripheral fructose concentrations. To our
knowledge, however, this theory had not been directly in-
vestigated, prompting the determination of leptin concen-
trations in the peripheral circulation during iv infusion of
fructose in monkeys. Plasma leptin concentrations were not
significantly different at any time point during fructose com-
pared with saline infusion (Fig. 3B), indicating that direct
exposure of white adipose tissue to significant elevations of
plasma fructose at a concentration of about 2 mm was not
sufficient to increase leptin secretion. In contrast, during
glucose infusion, there was a progressive increase of plasma
leptin concentrations relative to those measured during sa-
line infusion that was statistically significant after 240 min
and became more pronounced thereafter (P  0.001). There
were significant effects of time (P  0.02), treatment (P 
0.01), and a time treatment interaction (P 0.0001) for the
changes of plasma leptin during the infusions.
Discussion
Differential effects on insulin, leptin, and gastrointestinal
hormone secretion as well as on circulating lactate and lipids
and macronutrient oxidation have been reported in studies
comparing glucose and fructose ingestion in humans (7–11,
12, 26, 28, 31, 44). For instance, the lipogenic actions of in-
gested fructose results in substantially increased postpran-
dial triglycerides (9, 10) as well as potential effects to induce
liver triglyceride deposition and hepatic insulin resistance
(5). Of particular note are the smaller postprandial (begin-
ning 3–4 h after meals) and 24-h diurnal leptin concentra-
tions when fructose- comparedwith glucose-sweetened bev-
erages were consumed with mixed nutrient meals (9). A
reduced capacity for ingested fructose to increase circulating
leptin to the same degree as dietary glucose could result from
1) comparatively lower postprandial systemic exposure of
adipose tissue to this hexose due to its more limited gut
absorption compared with glucose (22–25) and/or its robust
uptake by the liver and rapid conversion to lactate and other
metabolites or 2) decreased adipocyte uptake and metabo-
lism of fructose leading to reduced leptin secretion. To ad-
dress these questions, we examined whether experimentally
elevated fructose concentrations in the peripheral circulation
achieved through iv fructose infusionwould increase plasma
leptin concentrations in rhesus monkeys. Fructose infusion
resulted in a steady-state plasma fructose concentration (2
mm) at least 4-fold higher than typical peak postprandial
levels determined after consumption of substantial quanti-
ties of fructose in humans (21, 26, 28, 48) (Teff, K. L., S. H.
Adams, and P. J. Havel, unpublished). Plasma leptin con-
centrations did not increase in the animals in response to
0 60 120 180 240 300 360 420 480
-2
-1
0
1
2
3
4
*
***
******
Infusion Time (min)
nitpeL a
msalP ni egnah
C
( ∆∆ ∆∆
)enilesab .sv l
m/gn 
0 60 120 180 240 300 360 420 480
-50
0
50
100
150
200
250
300
350
400
450
500
550 *
* *
*
*
**
***
Glucose
Fructose
Saline
nilusnI a
msalP ni egnah
C
( ∆∆ ∆∆
)enilesab .sv l
m/
Uµ 
A
B
FIG. 3. Changes of plasma insulin and leptin concentrations during
360-min iv infusions of saline, glucose, or fructose and in the 480-min
postinfusion sample in adultmale rhesusmonkeys. A, Plasma insulin
concentrations increased significantly during glucose infusion com-
pared with saline treatment (*, P 0.05; **, P 0.01; ***, P 0.001)
and returned to baseline levels after the termination of infusion.
Differences in insulin levels during fructose infusion compared with
saline infusion were not statistically significant, and levels were sig-
nificantly below those measured during glucose administration (60
and 180min,P 0.05; 90min,P 0.001; 120min,P 0.01). Baseline
fasting insulin concentrationswere 37.3 17.1U/ml (saline), 25.6
6.5 U/ml (glucose), and 26.5  5.2 U/ml (fructose). B, Relative to
saline infusion, plasma leptin concentrations were increased progres-
sively during glucose infusion by 240 min infusion and remained
elevated at least 2 h after the infusions (*, P  0.05; ***, P  0.001
vs. saline). Plasma leptin was not significantly increased during fruc-
tose infusion relative to saline treatment, and levels remained lower
than those measured during glucose infusion (240 and 300 min, P 
0.05; 360 and 480 min, P  0.001). Baseline fasting leptin concen-
trations were 4.4  2.0 ng/ml (saline), 4.9  2.2 ng/ml (glucose), and
4.7  2.4 ng/ml (fructose).
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fructose infusion, indicating that this degree of elevation in
plasma fructose concentration is not alone sufficient to stim-
ulate leptin production by adipose tissue in vivo.
In contrast to fructose, during glucose infusion in mon-
keys, there was a progressive increase of plasma leptin con-
centrations beginning at 4 h into the infusion consistent with
the known time course for insulin and glucose administra-
tion to increase circulating leptin concentration in human
subjects (9, 18, 49, 50). Glucose infusion was accompanied by
markedly increased plasma insulin concentrations, and in-
sulin is known to increase leptin expression and secretion
from adipocytes (13–16) through a mechanism that involves
increased oxidative glucose metabolism (17), whereas an-
aerobic metabolism of glucose does not increase leptin pro-
duction (18, 19, 51). In contrast, fructose is a poor insulin
secretagogue (52–54). Consistentwith theweak effect of fruc-
tose to trigger insulin secretion, steady-state plasma insulin
concentrations during fructose infusion in monkeys were
only marginally increased compared with baseline levels or
saline-infused animals in which plasma insulin levels were
modestly decreased during the infusion period. Limited in-
sulin responses to fructose administration are also observed
in humans, most likely as a result of small increases in blood
glucose concentrations that occur from conversion of in-
gested fructose to glucose (7, 9, 12, 28, 29, 31, 44, 48). One
consequence of these differences in insulin responses was a
significant decrease of plasma triglycerides during glucose,
but not during fructose or saline, infusions. In the fasted
state, circulating triglycerides are derived largely from liver
reesterification of lipolysis-derived free fatty acids. Triglyc-
eride concentrations likely decreased during glucose infu-
sion because the large increases of insulin activate lipopro-
tein lipase, suppress lipolysis, and increase free fatty acid
reesterification in adipose tissue. Similarly, the increased
anaerobic metabolism indicated by markedly elevated lac-
tate concentration during fructose compared with glucose
infusion is likely to be, at least in part, due to decreased
insulin-mediated flux of pyruvate derived from fructose me-
tabolism into mitochondrial oxidation though pyruvate de-
hydrogenase, an enzyme complex that is activated by insulin.
Based on limited data from studies in rat adipocytes in vitro,
there is evidence that insulin can stimulate fructose uptake
and metabolism in fat cells (55–57), albeit to a much lesser
degree than glucose (57). Thus, it is possible that the limited
insulin response during fructose infusion observed in vivo
results in decreased adipocyte utilization of fructose, mask-
ing any potential effects of the available fructose in the pe-
ripheral circulation. This possibility can be tested in exper-
iments measuring leptin responses during simultaneous
administration of fructose with and without exogenous in-
sulin administration.
Other factors that could contribute to differences in the
postprandial leptin response between glucose and fructose in
vivo include insulin-independent differences in utilization of
the two sugars by adipocytes and hexose accessibility to the
adipose tissue. Adipocytes are known to metabolize fructose
through mechanisms that rely on uptake through glucose
transporter 5 (GLUT5) (55–57) and possibly other hexose
transporters that are present in adipocytes (58). Froesch and
Ginsberg (55) determined that fructose uptake, utilization for
glycerol synthesis, and oxidative metabolism to CO2 were
relatively high in rat adipocytes (50–80% that of glucose),
and there is substantial metabolism of fructose to lipids in rat
adipocytes (59). Litherland et al. (57) reported fructose uptake
and conversion to lactate and triglyceride in isolated rat
adipocytes at concentrations of 100 m. Thus, the plasma
fructose levels observed in the current study would appear
to be well above those required for active metabolism of the
fructose by adipose tissue. It is possible, however, that leptin
secretion would be stimulated at higher plasma concentra-
tions of fructose, because uptake and metabolism of fructose
by rat adipocytes increases in a concentration-dependent
manner (55, 59), and leptin secretion from rat adipocytes is
increased during prolonged exposure to 5 mm fructose (17).
Nevertheless, leptin secretion at higher fructose concentra-
tions would not have direct relevance to the normal post-
prandial physiological state, because the plasma fructose
concentrations of about 2 mm achieved during fructose in-
fusion in the present study were well above those measured
(0.3–0.5 mm) after intake of substantive amounts of fruc-
tose in humans (21, 26, 28, 48) (Teff, K. L., S. H. Adams, and
P. J. Havel, unpublished).
One limitation of the current study to these interpretations
regarding leptin regulation is that steady-state plasma fruc-
tose concentrations during fructose infusion were signifi-
cantly lower compared with glucose concentrations during
the same rate of glucose infusion. The reason that fructose
levelswere lower likely reflects avid uptake of fructose by the
liver and its conversion to other metabolites, particularly its
anaerobic metabolism to lactate. A fraction of infused fruc-
tose was likely converted to glucose in the liver, as suggested
by the small but significant and progressive increase of
plasma glucose measured in the animals during infusion of
fructose. Small increases of glucose have also been observed
after fructose administration in humans (9, 26, 28, 29, 31, 36,
37, 39–42), and hepatic gluconeogenesis is stimulated by
fructose in a dose-dependent fashion in rats (60) and in
humans (45). It is also possible that some fructose spilled over
into the urine during the infusions; however, the potential
impact of this on steady-state plasma levels would be ex-
pected to be negligible considering that in humans, at most,
about 1% of fructose is recovered in the urine after enteral or
iv administration (39, 46, 47). Despite the limitations noted
with respect to steady-state differences in fructose and glu-
cose concentrations during glucose and fructose infusion, the
present data clearly indicate that experimental elevations of
peripheral fructose concentrations that are sufficient to result
in active tissue uptake and metabolism to lactate are not
sufficient to increase leptin production in vivo.
Summary
Marked increases of circulating lactate, a limited insulin
response, and relatively low leptin excursions have been
reported after fructose consumption in human studies. The
same pattern was observed in the present study during the
iv infusion of fructose when comparedwith glucose infusion
in rhesus monkeys. Directly increasing plasma fructose con-
centrations to about 2 mm by iv infusion of fructose did not
increase circulating leptin concentrations, indicating that in-
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creased exposure of adipose tissue to fructose per se cannot
alone stimulate leptin secretion by adipose tissue in vivo.
Therefore, previous reports of relatively attenuated post-
prandial 24-h diurnal circulating leptin responses to dietary
fructose in humans (9) may involve a limited effect of fruc-
tose to stimulate insulin secretion and/or a comparatively
large whole-body and adipocyte anaerobic conversion of
fructose to lactate.
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